New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis
Drug-resistant babesiosis may respond to a novel combination therapy, researchers say. The treatment, which involves the antimalarial drug tafenoquine and the anti-fungal/anti-parasite drug atovaquone, may also provide immunity ...
Jan 8, 2024
0
0